De F. Diniz
Alfenas, MG 37130001, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection.
Journal: Antimicrobial agents and chemotherapy
Published: December 13, 2019
Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi.
Journal: Antimicrobial agents and chemotherapy
Published: November 02, 2018
Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice.
Journal: Antimicrobial agents and chemotherapy
Published: February 28, 2018
Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
Journal: Biochemical pharmacology
Published: November 01, 2017
Myocarditis in different experimental models infected by Trypanosoma cruzi is correlated with the production of IgG1 isotype.
Journal: Acta tropica
Published: September 16, 2016
Mir-190b negatively contributes to the Trypanosoma cruzi-infected cell survival by repressing PTEN protein expression.
Journal: Memorias do Instituto Oswaldo Cruz
Published: May 12, 2015
Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock.
Journal: Parasitology
Published: July 22, 2014
Therapeutical approaches under investigation for treatment of Chagas disease.
Journal: Expert opinion on investigational drugs
Published: May 27, 2014
Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas disease.
Journal: Antimicrobial agents and chemotherapy
Published: May 21, 2014
Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.
Journal: PLoS neglected tropical diseases
Published: February 05, 2013
Last Updated: 09/26/2026